Yanfu Peng

Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells

Yong Ling, Jing Guo, Qiuxing Yang et al. · European Journal of Medicinal Chemistry · 2017 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

Design and Synthesis of C3‐Substituted β‐Carboline‐Based Histone Deacetylase Inhibitors with Potent Antitumor Activities

Yong Ling, Jiao Feng, Lin Luo et al. · ChemMedChem · 2017 · 34 citations

Medicine, Medicinal Chemistry, Pharmacology +14

A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects

Jiefei Miao, Yanfu Peng, Shi Chen et al. · European Journal of Pharmacology · 2018 · 26 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities

Liu Ji, Tingting Wang, Xinyang Wang et al. · MedChemComm · 2017 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells

Biao Xiong, Shi Chen, Peng Zhu et al. · Medicinal Chemistry · 2018 · 24 citations

Medicine, Medicinal Chemistry, Pharmacology +14